Prevalence and Factors Associated With Urologic Injury in Patients With Placenta Accreta Spectrum Undergoing Cesarean Hysterectomy Over a 10‐Year Retrospective Cohort at a Tertiary Referral Center in Shiraz, Iran Authors: Shaghayegh Moradi Alamdarloo, Zahra Ovaisi, Hamide Barzegar, Soroush Sadr, Alireza Dehghanmanshadi, Erfan Taherifard, Aazam Faraji, Khadije Bazrafshan, Mohammad Reza Ensafdaran, Atefe Hashemi Published: 2026 ABSTRACT ABSTRACTBackground and AimThis study assessed the prevalence, patterns, and risk factors of urologic injuries in patients with placenta accreta spectrum (PAS) undergoing cesarean hysterectomy, aiming to help clinicians identify high‐risk cases and optimize surgical planning.MethodsIn this retrospective cohort study with a 6‐month postoperative follow‐up, patients with a diagnosis of PAS referred to Namazi Hospital for treatment between January 2015 and December 2024. These patients were monitored for 6 months after their cesarean section for long‐term urologic complications, and their demographic information, obstetric history, hospitalization course, and operation detail were collected.ResultsA total of 115 patients (23.09%) had urologic injuries during cesarean section hysterectomy. Severe intraoperative blood loss (≥ 3000 mL), as a marker of surgical complexity, was strongly associated with urologic injury (adjusted OR 7.10, 95% CI 3.73–13.53; p < 0.001). Regarding pathology, placenta accreta was associated with a significantly lower risk of urologic injury compared with placenta percreta (adjusted OR 0.52, 95% CI 0.29–0.93; p = 0.03), whereas placenta increta was not significantly associated (adjusted OR 0.90, 95% CI 0.50–1.60; p = 0.71).ConclusionApproximately one‐fifth of pregnant women with PAS undergoing cesarean hysterectomy develop urologic injuries. This emphasizes on having a multidisciplinary team of surgeons with adequate experience in the field of abnormal placental tissue involvement. Besides, efforts should be taken preoperatively with the use of sufficient diagnostic means to optimize the surgical planning and management to reduce the amount of blood loss and prevent surgical morbidities such as urologic damage.Keywords: cesarean hysterectomy, morbid placentation, placenta accreta spectrum, urinary tract injury Abbreviations confidence interval placenta accreta spectrum Background Placenta accreta spectrum disorder (PAS) refers to a group of potentially life‐threatening conditions characterized by pathological adhesion or invasion of placental tissue into or over the uterine wall. This spectrum disorder is classified into three distinct histological and clinical categories based on the depth of involvement of the uterine wall: placenta accreta, increta, and percreta [1]. Placenta accreta is the most prevalent type of these three PAS subclasses, accounting for about three‐fourths of them [2]. The exact pathophysiology underlying reason for this abnormal placentation disorder is unknown. However, previous studies have indicated that improper decidualization on the scar of previous uterine surgery or cesarean section causes placental villi to attach to the myometrium, resulting in trophoblast invasion [3]. With the increasing number of cesarean sections in recent decades, the total prevalence of PAS has shown to experience a dramatic increase [4]. In a systematic review and meta‐analysis of 29 studies including more than five million births, the pooled prevalence of PAS was estimated to be 0.17% with 95% confidence interval (CI) of 0.14–0.19 [5, 6]. This spectrum disorder, itself, is associated with short‐term and long‐term maternal complications, including hemorrhage, shock, damage to pelvic or abdominal organs, loss of fertility, etc [7, 8, 9]. This issue could be more highlighted when some of its management approaches, such as cesarean hysterectomy have their own complications [10]. Besides, with an increase in the prevalence of PAS, its impact on morbidity and mortality and burden at both individual level and healthcare system level would be noticeable. Maternal urologic complications are among the major morbidities associated with abnormal placentation and represent some of the most common complications encountered during surgery for PAS disorders [11, 12]. These complications could be due to either the direct invasion of trophoblastic tissue into urinary tract system, or could occur intraoperatively, especially if a cesarean hysterectomy is attempted [13, 14]. These urologic complications include injuries at different level of the urinary system, rupture, formation of fistula, etc. In a national population‐based study in hospitals of Ireland, 403602 deliveries were evaluated, with placenta accreta in 357 deliveries [15]. In this study, it was revealed that the odds of adjacent organ damage and need for bladder repair or cystotomy were 8.2 (95% CI: 5.2–13.1) and 38.5 (95% CI: 21.8–68.1), respectively. In a systematic review on patients with PAS, 285 patients were identified to had hysterectomy and of those near to one third had unintentional injury to the urinary tract [16]. Early detection and management of these urinary tract injuries could help the patient to have an optimal recovery and the least possible sequels. Determination of risk factors associated with a higher rate of urologic injuries in those patients with PAS undergoing cesarean hysterectomy guide the obstetric team to identify high‐risk patients, and consequently take necessary actions to reduce the surgery risk. There is a limited body of evidence on these risk factors in patients with PAS. In this study, we aimed to assess the prevalence, pattern, and risk factors associated with urologic injuries in PAS patients with cesarean hysterectomy. Materials and Methods Study Setting and Participants This retrospective cohort study was conducted to assess the prevalence of urologic injuries among patients undergoing cesarean hysterectomy and with a diagnosis of PAS. Here, patients with a diagnosis of PAS, either preoperatively using imaging techniques or intraoperatively, who were referred to Shiraz Namazi Hospital, a tertiary referral center in southern Iran, for treatment, were evaluated. In these patients, the approach for hysterectomy was through abdominal route and a total hysterectomy with excision of the cervical part from the vagina was performed. The time period of patient selection for this study was between January 2015 and December 2024. These patients were monitored for 6 months after their cesarean section for long‐term urologic complications such as fistula or urologic resurgery. The protocol of the study was approved by the institutional review board of Shiraz University of Medical Sciences (IR.SUMS.REC.1400.670). Informed written consent was collected from all patients before enrollment. This study was conducted in accordance with the 1964 Helsinki Declaration. Inclusion criteria for this study were singleton pregnancies undergoing cesarean hysterectomy due to PAS. The diagnosis and depth of placental invasion were confirmed by an experienced pathologist, and histopathology was used as the reference standard for PAS classification. Besides, those patients who received conservative management for morbid placentation were not considered in this study. Although PAS was suspected preoperatively based on imaging or intraoperatively during surgery, the final classification of placenta accreta, increta, or percreta was based exclusively on histopathologic examination and was considered the reference standard. In all cases, a urologist was present or consulted intraoperatively and systematically evaluated the urinary tract after completion of the hysterectomy and before abdominal closure to identify and immediately repair any bladder or ureteral injuries. Patients were followed for up to 6 months after cesarean hysterectomy to identify delayed urologic complications. Data Collection Patients were asked about their demographic information, including age, gravidity, live birth, previous history of cesarean section, history of dilation and curettage, and gestational age at the diagnosis. Furthermore, information regarding the patients’ hospitalization course, such as gestational age, termination time, and length of staying in the hospital were collected. Operation detail includes urologic problems (bladder, ureter, and bladder fistula), as well as the requirement for a urologist, intraoperative bleeding volume, blood transfusion rate, operation duration, intestinal injury, the requirement for the presence of a vascular surgeon, and packing necessity. The final diagnosis of PAS considered for the patients in this study was based on the report of the pathologist. The primary outcome was occurrence of any urologic injury during or after cesarean hysterectomy. Urologic injury was defined as any intraoperative or postoperative injury to the urinary tract attributable to the cesarean hysterectomy. Intraoperative bladder injury was defined as an unintended cystotomy requiring immediate repair. Ureteral injury included ureteral transection, ligation, or devascularization identified intraoperatively or postoperatively. Delayed urologic injury was defined as a postoperative vesicovaginal or ureterovaginal fistula diagnosed during the 6‐month follow‐up period. Statistical Analysis International Business Machines Corporation Statistical Package for Social Sciences (IBM SPSS) version 24 (CA, USA) was used for data management and statistical analysis. Data cleaning was first conducted and double‐checked for internal and external consistencies. Normality was assessed using the Shapiro–Wilk test. Statistical analyses were conducted following established guidelines to ensure transparent reporting [17]. Frequencies and relative frequencies were estimated and reported for categorical and continuous variables are presented as mean ± standard deviation for descriptive purposes and were compared using the Mann–Whitney U‐test because several variables were not normally distributed. For univariate analyses, Chi‐square test, Fisher's Exact test, and Mann–Whitney U‐test were applied. Adjusted and crude odds ratio (OR) estimates and their 95% CI were also calculated. For the assessment of adjusted OR, multiple logistic regression analysis was applied. Variables included in the multivariable logistic regression model were selected a priori based on clinical relevance, prior literature, and biological plausibility, in order to avoid model overfitting given the number of events. Other potential predictors, such as a history of prior uterine surgery (e.g., myomectomy), were extremely rare in our cohort (only one patient) and therefore were not included in the regression models. Estimated blood loss was included in the multivariable model as an intraoperative surrogate marker of surgical complexity rather than as a preoperative causal risk factor. The primary outcome variable was the occurrence of any urologic injury, as defined above. A p‐value less than 0.05 was considered statistically significant. Ethics Approval and Consent to Participate The study protocol was approved by the Ethics Committee of Shiraz University of Medical Sciences (Approval code: IR.SUMS.REC.1400.670) and was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants prior to enrollment in the study. Results During the 10‐year study period, 498 women with a diagnosis of PAS underwent cesarean hysterectomy. Overall, 115 patients (23.09%) sustained urologic injuries, most commonly bladder injuries (n = 100), followed by ureteral injuries (n = 14), and one combined bladder and ureteral injury. On 6‐month follow‐up, only one patient developed a fistula, likely reflecting early intraoperative detection and repair of urologic injuries. One patient developed a delayed vesicovaginal fistula during follow‐up. Based on final histopathologic assessment, 217 patients (43.57%) were classified as placenta accreta, 145 (29.11%) as increta, and 121 (24.29%) as percreta. Table 1 presents a comparison of baseline characteristics, clinical features, and other measured variables between patients with and without urologic injury. Table 1Comparison of baseline, demographic, and other measured factors of the patients with and without urologic injury.VariablesTotal (n = 498)Analysis group according to urologic injuryPatients with urologic injury (n = 115)Patients without urologic injury (n = 383) p‐valueAge(year)33.93 ± 4.7234.29 ± 4.4333.82 ± 4.80.35Gravidity3.79 ± 1.571.30 ± 3.721.65 ± 3.820.99Live births2.03 ± 1.071.04 ± 2.071.08 ± 2.020.66Abortion0.65 ± 0.990.90 ± 0.611.03 ± 0.670.65Death0.20 ± 0.520.63 ± 0.220.49 ± 0.200.72Number of prior CD1.92 ± 0.932.01 ± 0.91.89 ± 0.940.15Number of prior curettage70 (14.0%)21 (18.20%)49 (12.90%)0.17Depth of invasion (pathology)Accreta217 (43.57%)33 (29.50%)184 (49.60%)< 0.001Increta145 (29.11%)39 (34.80%)106 (28.60%)0.20Percreta121 (24.29%)40 (35.70%)81 (21.80%)0.002Missing15 (3.01%)3 (2.60%)12 (3.13%)GA at operation (weeks)0.01< 2453 (10.64%)15 (13.0%)38 (10.10%)24–33137 (27.51%)44 (38.30%)93 (24.70%)34–37239 (47.90%)46 (40.0%)193 (51.20%)≥ 3763 (12.65%)10 (8.70%)53 (14.10%)Blood loss< 0.001≤ 1000151 (30.32%)15 (13.30%)136 (36.40%)1000–2000134 (26.90%)22 (19.50%)112 (29.90%)2000–300070 (14.05%)13 (11.50%)57 (15.20%)≥ 3000132 (26.50%)63 (55.80%)69 (18.40%)Estimated blood loss, mL2247.72 ± 1674.523445.61 ± 2076.621816.2 ± 1311.76< 0.001RBC units transfused3.47 ± 2.882.73 ± 3.332.94 ± 3.530.73FFP units transfused4.15 ± 2.352.03 ± 3.752.46 ± 4.030.14Platelet units transfused4.27 ± 2.411.72 ± 4.02.59 ± 4.360.64Length of hospital Stay, days3.96 ± 2.394.17 ± 2.973.89 ± 2.200.35 Note: Data are presented as n (%) (Chi‐square/Fisher's Exact Test) for categorical variables and Mean ± SD (Mann–Whitney U‐test) for continuous variables. Abbreviations: CD, cesarean delivery; FFP, fresh‐frozen plasma; GA, estimated gestational age; RBC, red blood cell; VVF, vesicovaginal fistula. Comparison of baseline, demographic, and other measured factors of the patients with and without urologic injury. Note: Data are presented as n (%) (Chi‐square/Fisher's Exact Test) for categorical variables and Mean ± SD (Mann–Whitney U‐test) for continuous variables. Abbreviations: CD, cesarean delivery; FFP, fresh‐frozen plasma; GA, estimated gestational age; RBC, red blood cell; VVF, vesicovaginal fistula. Because of the limited number of ureteral injuries, regression analyses were performed for overall urologic injury rather than injury subtype. Among patients with urologic injury, 40 individuals (35.70%) had placenta percreta, compared with 29.5% and 34.8% who had placenta accreta and placenta increta, respectively. Women with urologic injury had more operative blood loss (3445.61 ± 2076.62 mL vs. 1816.2 ± 1311.76 mL). No differences were observed between patients with and without urologic injury regarding women's age, history of gravidity, live births, abortion, neonatal death, number of prior CD, and curettage. Table 2 summarizes the results of univariate and multivariable logistic regression analyses evaluating preoperative and intraoperative factors associated with urologic injury. The multivariable model included variables considered clinically important; the events‐per‐variable ratio was sufficient to avoid overfitting. Variables with extremely low prevalence, such as prior myomectomy (n = 1), were excluded from the multivariable model. Increasing age and number of prior cesarean deliveries were not significantly associated with urologic injury in either univariate or adjusted analyses. Table 2Preoperative and intraoperative factors associated with urologic injury.VariablesUnivariate regressionMultiple regressionCrude OR95% CI p‐valueAdjusted OR95% CI p‐valueAge1.0140.971–1.0600.521.0170.966–1.0700.53Number of prior CD1.1450.917–1.4290.231.0890.846–1.4010.50Estimated blood loss (mL)≤ 1000ReferenceReference1000–20001.8790.936–3.7720.071.8620.923–3.7570.082000–30002.0680.925–4.6230.071.6430.704–3.8340.25≥ 30008.2874.395–15.594< 0.0017.1013.726–13.533< 0.001Depth of invasionPercretaReferenceReferenceAccreta0.3630.214–0.617< 0.0010.5230.294–0.9290.03Increta0.7540.440–1.2630.270.8990.504–1.6030.72Emergency surgery0.9510.617–1.4660.820.8510.524–1.3830.51 Note: Our outcome variable was “Urologic Injury.” Estimated blood loss represents an intraoperative variable and should be interpreted as a marker of surgical complexity rather than a preoperative risk factor. On 6‐month follow‐up, only one patient developed a fistula and underwent surgical repair. Abbreviations: CI, confidence interval; CD, cesarean delivery; OR, odds ratio. Preoperative and intraoperative factors associated with urologic injury. Note: Our outcome variable was “Urologic Injury.” Estimated blood loss represents an intraoperative variable and should be interpreted as a marker of surgical complexity rather than a preoperative risk factor. On 6‐month follow‐up, only one patient developed a fistula and underwent surgical repair. Abbreviations: CI, confidence interval; CD, cesarean delivery; OR, odds ratio. An estimated blood loss ≥ 3000 mL, reflecting increased intraoperative surgical complexity, was strongly associated with urologic injury. Regarding the depth of placental invasion, placenta percreta was used as the reference category. In univariate analysis, placenta accreta was associated with a significantly lower risk of urologic injury (crude OR 0.36, 95% CI 0.21–0.62; p < 0.001), and this association remained significant in the multivariable model (adjusted OR 0.52, 95% CI 0.29–0.93; p = 0.03). Placenta increta was not significantly associated with urologic injury in either univariate or multiple regression analyses. Discussion In this large cohort of women with PAS undergoing cesarean hysterectomy, urologic injury emerged as a frequent intraoperative complication. Urologic injuries in PAS surgery represent a heterogeneous group with distinct mechanisms and clinical implications. Bladder injuries, which accounted for the majority of cases in our cohort, are often related to dense vesicouterine adhesions and distorted anatomy, whereas ureteral injuries are less common but carry a higher risk of delayed diagnosis and long‐term morbidity. Although fistula formation was rare in our study, it represents the most severe form of urologic injury and underscores the importance of careful intraoperative assessment and postoperative surveillance. The distribution of placental invasion depth differed among patients with urologic injury, with more advanced forms of abnormal placentation being prominent. Severe intraoperative blood loss was strongly associated with urologic injury and remained an independent predictor after adjustment for confounders. In contrast, less invasive placental pathology was associated with a lower likelihood of urologic injury compared with the most severe form. Overall, these findings highlight the close relationship between the severity of placental invasion, operative complexity, and the risk of urologic injury during PAS surgery. The morbidly adherent placenta is associated with an increased risk of urinary tract injuries in cesarean section. In general, the prevalence of urinary tract injuries has shown to be more in obstetric surgeries in comparison to the gynecological surgeries [18]. The rate of injuries to the urinary tract during cesarean section is less than 0.5% for lower urinary tract injuries, mostly bladder injuries, and less than 0.1% for ureteral injuries [19, 20, 21, 22]. However, in patients with morbidly adherent or invasive placenta, this rate is much higher. In a retrospective study by Alanwar et al., 342 pregnant patients with placenta accreta who underwent cesarean section were assessed [13]. It was reported that in 21.7% of the studied women, the urinary tract was damaged in the midst of the operation. Consistently, in our study, the prevalence of urinary tract injury was 23.09%, which is far greater than the counterpart in those without morbid placental adherence/invasion. In individuals with percreta, the placental tissue could breach the uterine serosa. In addition, chorionic villi could also be seen in other pelvic tissue or organs such as the urinary system and rectum [23]. Invasion of placenta percreta into the urinary bladder makes the obstetrician to remove at least the invaded parts of its wall, if applicable, which requires further wall reconstruction [24]. Therefore, the risk of urinary system injury may increase with higher grades of placental invasion. Likewise, the prevalence of urinary tract injuries was higher among patients with placenta percreta compared with those with placenta accreta or increta in this study. There are also other reasons that may contribute to the higher rate of urinary tract injury in patients with PAS. Based on the grade and depth of involvement in accreta spectrum disorder, the anatomy of organs within the pelvic cavity and even the abdominal cavity could be distorted [23, 25]. In addition, cesarean hysterectomy is typically needed, particularly in pregnant women with extensive placental adhesion and those with invasive placental tissue [1, 5, 26]. As the urinary bladder lies inferior to the body of the uterus, it is at increased risk of damage during the operation. Severe intraoperative blood loss was independently associated with urologic injury in our cohort. However, blood loss should not be interpreted as a causal preoperative risk factor. Rather, it likely reflects greater surgical complexity, distorted pelvic anatomy, extensive neovascularization, and advanced placental invasion, all of which increase the technical difficulty of cesarean hysterectomy and the risk of adjacent organ injury. A similar finding was reported in a study conducted by Radu et al. [14], and patients who developed urologic injuries during cesarean delivery were evaluated. It was reported that intraoperative blood loss was statistically significantly higher among those with damage to the urinary system compared to their matched controls without urologic injury. Based on these studies, we can conclude that a higher amount of hemorrhage at the time of cesarean hysterectomy could be indicative of a greater extent of abundant neovascularization in patients with PAS. This issue could add to the complexity of the operation and a higher rate of damage to adjacent organs. Therefore, in addition to the necessity of having highly experienced surgeons for these patients, surgeons may need to take the required actions to lower the amount of bleeding intraoperatively. Different surgical techniques, such as bladder hydrodissection for PAS patients, have shown favorable results in reducing the rates of complications and intraoperative bleeding [27]. These findings have several important clinical implications. First, accurate preoperative identification of patients with placenta percreta using imaging is essential to guide surgical planning. Second, involvement of a urologist during cesarean hysterectomy should be considered mandatory for cases with suspected percreta to enable immediate detection and repair of urinary tract injuries. Third, in selected high‐risk patients, prophylactic ureteral stenting may be considered to reduce the risk of ureteral injury. Finally, referral to high‐volume centers experienced in the management of PAS may improve outcomes by ensuring access to multidisciplinary teams and advanced surgical expertise. A key strength of our study is the routine intraoperative evaluation of the urinary tract by a urologist prior to abdominal closure, which likely contributed to prompt identification and repair of injuries and the low incidence of delayed urologic complications. Use of histopathologic confirmation as the reference standard for PAS classification strengthens the internal validity of our findings and minimizes misclassification bias. Conducted over a 10‐year period in a referral center, patients’ demographic and hospitalization information were collected at admission, and short‐term urologic complications were recorded before discharge. In addition, patients were followed for 6 months to capture detailed information on long‐term urologic complications, such as fistula. One limitation of the study is the involvement of different surgeons with varying levels of experience, which may have influenced the outcomes. Our analysis grouped different types of urologic injury into a single composite outcome, which may obscure differences in mechanisms and severity between bladder and ureteral injuries. Our study lacked certain potentially important confounders, including antenatal diagnosis of PAS, use of prophylactic ureteral stents, preoperative cystoscopy, and surgeon experience (years or case volume). These factors could influence the risk of urologic injury by affecting operative planning, surgical technique, or intraoperative detection of injuries. For instance, antenatal diagnosis may allow preoperative planning with multidisciplinary teams, and surgeon experience may reduce complications. Future multicenter studies including these variables are warranted to better quantify their impact. For future research, multicenter studies are recommended to validate and generalize these findings. Conclusion This study revealed that approximately one‐quarter of pregnant women with PAS undergoing cesarean hysterectomy develop urologic injuries. This emphasizes on the necessity of having a multidisciplinary team of surgeons with adequate experience in the field of abnormal placental accreta during surgery. Besides, efforts should be taken preoperatively with the use of sufficient diagnostic means to optimize surgical planning, manage operative complexity, and reduce severe hemorrhage, thereby potentially decreasing the risk of urologic injury. Author Contributions Shaghayegh Moradi Alamdarloo: conceptualization, writing – review and editing, writing – original draft. Zahra Ovaisi: data curation, visualization, writing – original draft. Hamide Barzegar: conceptualization, writing – original draft, writing – review and editing. Soroush Sadr: writing – original draft, data curation, writing – review and editing. Alireza Dehghanmanshadi: writing – original draft, writing – review and editing, data curation. Erfan Taherifard: writing – original draft, writing – review and editing, data curation. Aazam Faraji: conceptualization, writing – original draft, writing – review and editing. Khadije Bazrafshan: data curation, writing – review and editing, writing – original draft. Mohammad Reza Ensafdaran: writing – review and editing, writing – original draft, supervision. Atefe Hashemi: conceptualization, supervision, writing – review and editing, writing – original draft. Funding The authors have nothing to report. Ethics Statement The study protocol was approved by the Ethics Committee of Shiraz University of Medical Sciences (Approval code: IR.SUMS.REC.1400.670) and was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants prior to enrollment in the study. Consent The authors have nothing to report. Conflicts of Interest The authors declare no conflicts of interest. Transparency Statement Atefe Hashemi, as the manuscript guarantor, affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned have been explained. Acknowledgments The authors would like to thank Shiraz University of Medical Sciences, Shiraz, Iran, and also the Center for Development of Clinical Research of Namazi Hospital and Alimohammad Keshtvarz Hesam Abadi for statistical assistance. Data Availability Statement The data supporting the findings of this study are not publicly available due to institutional and patient privacy restrictions but are available from the corresponding author upon reasonable request. References Associated Data Data Availability Statement The data supporting the findings of this study are not publicly available due to institutional and patient privacy restrictions but are available from the corresponding author upon reasonable request.